1-7 of 7
Authors: Taylor Garcia
Journal Article
CBIO-03. ATRX LOSS IN GLIOMA RESULTS IN EPIGENETIC DYSREGULATION OF CELL CYCLE PHASE TRANSITION
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii16, https://doi.org/10.1093/neuonc/noaa215.063
Published: 09 November 2020
Journal Article
GENE-17. ATRX LOSS IN GLIOMA RESULTS IN EPIGENETIC DYSREGULATION OF THE G2/M CHECKPOINT AND SENSITIVITY TO ATM INHIBITION
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi101, https://doi.org/10.1093/neuonc/noz175.419
Published: 11 November 2019
Journal Article
HGG-03. EVEROLIMUS TREATMENT IMPROVES THE CNS PENETRATION AND EFFICACY OF DASATINIB IN THE TREATMENT OF PDGFRA-DRIVEN PEDIATRIC HIGH-GRADE GLIOMA AND DIFFUSE INTRINSIC PONTINE GLIOMA
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii87, https://doi.org/10.1093/neuonc/noz036.097
Published: 23 April 2019
Journal Article
HGG-08. ATRX LOSS IN PEDIATRIC GBM RESULTS IN EPIGENETIC DYSREGULATION OF G2/M CHECKPOINT MAINTENANCE AND SENSITIVITY TO ATM INHIBITION
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii88, https://doi.org/10.1093/neuonc/noz036.102
Published: 23 April 2019
Journal Article
Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations
Neuro-Oncology, Volume 21, Issue 8, August 2019, Pages 968–980, https://doi.org/10.1093/neuonc/noz022
Published: 26 February 2019
Journal Article
PDTM-29. CSF H3F3A K27M CIRCULATING TUMOR DNA COPY NUMBER QUANTIFIES TUMOR GROWTH AND TREATMENT RESPONSE
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Pages vi209–vi210, https://doi.org/10.1093/neuonc/noy148.870
Published: 05 November 2018
Journal Article
DIPG-38. ID1 EXPRESSION CORRELATES WITH H3F3A K27M MUTATION AND EXTRA-PONTINE INVASION IN DIPG
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i56, https://doi.org/10.1093/neuonc/noy059.131
Published: 22 June 2018
